JPX-1188

N/A

Report date: 2023/03/12 14:23:29
NME

Base Information

Drug NameJPX-1188
Drug Alias NameJPX-1188
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitorsSTAT5 transcription factor inhibitors
TargetsSignal transducer and activator of transcription 3STAT5 transcription factor
Therapy Area/IndicationsLeukemia, Myeloid, AcuteLeukemia, Prolymphocytic, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanpix Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanpix Ltd
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, AcuteLeukemia, Prolymphocytic, T-Cell

Other Information

ATC CodeN/A
Related LinksN/A